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Colon cancer in the elderly: evidence for major
improvements in health care and survival
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Summary Time trends in therapeutic approaches and in the prognosis of colon cancer for patients aged 75 years and above have been
investigated in comparison with corresponding trends for younger patients using a population-based series of 2089 colon cancer patients
diagnosed between 1976 and 1990 in the C6te-d'Or area (478 000 inhabitants), Burgundy, France. Significant progress has been achieved in
the management of patients with colon cancer in both age groups, buttrends have been more noticeable in patients aged 75 years and above.
In the elderly, the proportion of cancers limited to the digestive tract wall showed a 3-year average increase of 2.8% (P = 0.02) and the
frequency of curative surgery an average increase of 8.6% (P< 0.001), so that it was performed in 80% of cases in the last 3-year period.
Operative mortality decreased by 2.5% between 3-yearperiods (P < 0.004). Crude 5-yearsurvival rates in elderly patients increased from 15%
in the 1976-78 period to 29% in the 1985-87 period (P< 0.001), the corresponding figures being 36% and 44% (P> 0.10) in younger patients.
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Colon cancer is a major problem in elderly patients. Incidence
rates rise with age, and over 40% of cases occur in subjects over
the age of74. Recent studies have demonstrated an increase in the
incidence of colon cancer in several areas of the Western world
(Coleman et al, 1993) and, given the increasing life expectancy of
Western populations, an ever-growing number of aged people is
exposed to the risk ofcolon cancer. Age has often been considered
as a negative factor in the prognosis for this cancer. However, raw
survival data, from which such conclusions are usually drawn,
overestimate mortality due to the malignancy under investigation,
especially in elderly patients, for whom mortality owing to other
causes is high, and tend to conceal the progress that has been
achieved in the perioperative management ofelderly patients over
the past 15 years (Pillon et al, 1991). Data on therapeutic
approaches and on the prognosis of colon cancer patients have
mostly been provided by specialized hospital units, with unavoid-
able selection bias, especially for elderly patients. The aim ofthis
study is to draw apicture oftime trends in the diagnosis, treatment
and prognosis ofcolon cancers seen during the 1976-90 period in
a non-selected community-based series of patients aged 75 years
or older, and to make comparisons with the corresponding trends
in younger patients.
SUBJECTS AND METHODS
Study population
Since 1 January 1976, the Registry of Digestive Cancers at Cote-
d'Or, Burgundy, France, has recordedevery case ofdigestive cancer
occurring among subjects living in the area (478 000 inhabitants
according to the 1982census). Thecompleteness anddataquality of
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the Registry are certified every 4 years by an audit ofthe National
Institute for Health and Medical Research (INSERM), which
provides funding. During the 15-year period 1976-90, 2089 cases
ofcolon cancer were diagnosed. The 914 patients aged 75 years or
olderrepresented 43.8% ofall cases. The MIF sex ratio was 0.71.
Outcome measures
The spread ofeach malignancy at the time ofdiagnosis was classi-
fied, for resected cancers, according to Dukes (1932), as: limited
to the digestive wall (Dukes A) (I, see tables); extension beyond
the digestive wall (Dukes B) (II); and lymph node involvement
(Dukes C) (Ill). In the absence of resection, cancers were
classified as either metastatic (IV) or of undetermined stage (i.e.
absence of detectable metastasis) (V). Treatment procedures were
defined as: surgery for cure, i.e. complete tumour removal with
tumour-free margins (1); palliative resection (II); palliative
surgery with no tumour resection (i.e. colostomy or explorative
laparotomy) (III); and medical treatment without surgery, i.e.
chemotherapy, radiotherapy or purely palliative treatment (IV). As
the impact of age and other factors on operative mortality and on
long-term mortality after surgery may be different, we decided to
study the two separately. Operative mortality was defined as death
within 30 days of surgery and long-term mortality comprised all
other deaths. Complete follow-up to May 1992 was obtained for
97.1% of the patients. Information on operative mortality was
obtained for 97.8% ofsurgically treated patients.
Statistical analysis
In the elderly (2 age 75), time trends for the percentage frequency
of different stages at diagnosis and different therapeutic
approaches and for operative mortality and 5-year survival were
studied by the period of diagnosis (on a 3-year basis) for both
sexes combined and for men and women separately. The crude
3-yearly changes in the proportions were computed as linear
regression coefficients (using BMDP software; Dixon et al.,
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Table 1 Time trends by stage at diagnosis and age group (by 3-year periods), both sexes combined
< 75 years (n = 1173) > 75 years (n = 914)
Study period Stage atdiagnosisa (%) Stage atdiagnosis (%)
n I II Ill IV V n I II Ill IV V
1976-78 197 12.2 31.5 22.8 28.9 4.6 129 5.4 21.7 30.2 26.4 16.3
1979-81 220 14.5 37.3 19.1 26.4 2.7 168 10.1 33.3 22.6 21.4 12.5
1982-84 228 18.9 33.8 21.5 22.4 3.5 200 10.0 38.0 20.0 22.5 9.5
1985-87 267 21.3 30.3 24.3 19.5 4.5 200 20.0 33.0 25.0 14.5 7.5
1988-90 261 21.5 32.6 25.7 16.5 3.8 217 14.3 36.9 30.0 14.3 4.6
Mean % change
between periods 2.5 -0.5 1.1 -3.2 0.0 2.8 3.0 0.2 -3.1 -2.8
Males 3.1 1.3 -2.2 0.3 -2.5
Females 2.4 4.2 1.9 -5.5 -3.0
P-value for trend 0.005 0.64 0.12 0.001 0.89 0.02 0.11 0.81 0.004 <0.001
Males 0.11 0.57 0.43 0.99 0.03
Females 0.06 0.11 0.08 <0.001 0.001
aStage at diagnosis: I, cancers limited to the digestive tract wall; II, extension beyond the digestive tractwall; III, lymph node involvement; IV, distant metastasis;
V, undetermined stage.
1981), and associated probabilities for heterogeneity and trend
were derived from logistic regression analyses (using GLIM;
Payne, 1987). Otherpercentages werecompared using the Pearson
chi-square test ofheterogeneity.
Both crude and relative survival rates were computed.
Survival was studied according to age, stage at diagnosis, treat-
ment and time period. Crude survival curves were established
using the actuarial method and compared using the log-rank test
(again using the BMDP software; Dixon et al, 1981). Relative
survival curves were established according to Ederer using the
software written by Hakulinen et al (1985). Relative survival was
defined as the ratio of crude survival over expected survival
derived from rates in a population ofthe same age and sex distri-
bution. Baseline probabilities for survival and life expectancy of
the French population were provided by sex and age, for indi-
vidual years for the period 1981-83, by INSEE (The National
Institute for Statistics and Economic Studies). Relative survival
curves were compared using the maximum likelihood ratio test.
The Hakulinen software also enabled us to calculate loss in life
expectancy for each stratum and relative risks of death for
elderly patients by reference to the group of patients under the
age of75 years.
RESULTS
Time trends in stage at diagnosis
The percentage distribution for each stage at diagnosis by 3-year
periods, in elderly and in younger patients, is presented in Table 1.
Among theelderlypatients, theproportionofnon-metastatic cancers
increased, whereas metastatic cancers or cancers of undetermined
stage displayed a negative trend over the study period. The average
3-yearly changes are given in Table 1 together with probabilities
associated with the trends. For cancers limited to the digestive tract
wall, thechange was +2.8% (P =0.02); forcancers invading beyond
thedigestive tract wall, +3.0% (P>0.1); and forcancers with lymph
node involvement, +0.2% (P > 0.1). Conversely, there were highly
significant decreases in the proportion of cancers diagnosed at the
metastatic stage, -3.1% (P = 0.004), and in the proportion of
cancers ofundetermined stage, -2.8% (P <0.001).
Forelderlypatients, time trends were more noticeable in women
than in men (Table 1). For men, the proportion of metastatic
cancers was relatively stable (+0.3%, P >0.10), whereas for
women there was a significant decrease of 5.5% (P < 0.001).
However, the mean proportion of metastatic cancers over the
whole study period was similar in women (19.3%) and in men
(18.9%). For cancers ofundetermined stage, there were significant
trends for both men (-2.5%, P = 0.03) and women (-3.0%,
P=0.001). For cancers limited to the digestive tract wall, the
3-year mean crude changes were +3.1% (P> 0.1) for men and
+2.36% (P = 0.06) for women. The increase in cancers limited to
the digestive tract wall and the decrease in metastatic cancers
described above were also observed in the younger age group, but
only elderly patients displayed the decrease in the proportion of
cancers of undetermined stage (Table 1). In the 1976-78 period,
these cancers represented 16.3% of the cases in elderly patients
and4.6% in youngerpatients; thecorresponding proportions in the
1988-90period were 4.6% and 3.8%.
Time trends in therapeutic approaches
Duringthe 15-yearstudyperiod, thefrequency ofcurative surgery in
the elderly increased by 8.6% (P <0.001) between 3-year periods.
There was no significantchange in thefrequency ofpalliative resec-
tion (+0.7%, P> 0.10), whereas the frequency of surgery without
resection decreased significantly with a mean change of -4.7%
(P <0.001) per 3 years. The proportion receiving medical treatment
decreased on average by 4.6% between periods (P < 0.001). Time
trends were again more noticeable in women than in men. The
average 3-year changes in curative surgery were +6.3% (P =0.04)
in men and +10.0% (P<0.001) in women; for surgery without
resection, theproportions decreased on averageby 4.4% (P <0.001)
and 5.0% (P <0.001) respectively; for medical treatment, the
corresponding values were -3.1% (P = 0.04) and -5.6% (P <0.01).
However, the mean rate of curative surgery over the whole study
period was slightly lower in women (64.7%) than in men (67.7%).
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Table 2 Time trends in therapeutic approach and age-group (by 3-year period), both sexes combined
< 75 years (n = 1173) > 75 years (n = 914)
Study period Therapeutic approacha (%) Therapeutic approach (%)
n I II IlIl IV n I II III IV
1976-78 197 61.9 16.3 13.7 8.1 129 45.7 7.0 20.9 26.4
1979-81 220 68.2 18.2 6.8 6.8 168 58.3 10.1 16.1 15.5
1982-84 228 71.1 16.2 5.7 7.0 200 60.5 12.5 11.0 16.0
1985-87 267 77.5 13.5 4.5 4.5 200 76.0 8.5 5.0 10.5
1988-90 261 81.6 12.2 3.5 2.7 217 79.7 11.5 2.8 6.0
Mean % change
between periods 4.9 -1.3 -2.3 -1.3 8.6 0.7 -4.7 -4.6
Males 6.3 1.1 -4.4 -3.1
Females 10.0 0.5 -5.0 -5.6
P-value for trend: 0.006 0.1 <0.001 0.007 <0.001 0.41 <0.001 <0.001
Males 0.04 0.50 <0.001 0.04
Females <0.001 0.56 <0.001 <0.001
atherapeutic approach: I, curative resection; II, palliative resection; III, palliative surgery without resection; IV, medical treatment.
Table 3 Five year survival according to stage at diagnosis in patients aged 75 and over
Stage at diagnosiss Number of cases Crude survival Relative survival Number of years Loss of life
% (SE) % (SE) of life lost expectancy(%)
All cancers
83 55.6 (5.5) 93.2 (9.3) 0.6 10
11 223 38.7 (3.3) 69.8 (5.9) 2 24
III 163 14.9 (2.8) 28.3 (5.4) 4 56
IV 143 1.6 (1.1) 2.7 (1.9) 6 88
V 76 6.6 (2.8) 14.1 (5.1) 4 73
P <0.001 <0.001*
Cancers treated by curative resection
73 62.3 (5.7) 100.0 (9.6) 0 0
11 190 45.4 (3.6) 79.9 (6.4) 1 14
III 95 25.7 (4.5) 46.3 (8.1) 3 40
P <0.001 * <0.001 **
aStage at diagnosis: I, cancers limited to the digestive tract wall; II, extension beyond the digestive tract wall; III, lymph node involvement; IV, distant metastasis;
V, undetermined stage.
*Logrank estimate; **maximum likelihood estimate; SE, standard error.
Comparisons of therapeutic approaches in elderly and younger
patients by 3-year periods are also presented in Table 2. Trends
followed the same direction for both age groups but were more
marked in elderly patients. Although the rate of curative surgery
was higher in younger than in elderly patients in the 1976-78
period (61.9% and 45.7% respectively), it evened out in the two
age groups in the most recent 3-year period (81.0% vs 79.7%).
Time trends in operative mortality
Operative mortality decreased on average by 2.5% between
3-year periods (P = 0.004) in patients aged 75 years and over. This
decrease was slightly more noticeable in women (-2.8%, P = 0.09)
than in men (-2.2%, P = 0.10). After curative resection, the 3-year
decrease was 4.0% (P = 0.001). Operative mortality after curative
surgery decreased even more noticeably in younger patients (from
17.4% in 1976-78 to 1.5% in 1988-90, P = 0.001), whereas corre-
sponding figures were 25.4% and 8.1% in the elderly (P = 0.001).
Prognosis
The crude 5-year survival rate was higher in younger patients than
in older patients (41.2% vs 23.8%, P < 0.001), but there was no
significant difference in corresponding relative survival rates
(46.8% vs 43.3%, P > 0.10). After curative resection, excluding
post-operative deaths, crude survival rates were 60.7% and 43.4%
(P < 0.001) respectively, and relative survival rates were 68.5%
and 75.9% (P> 0.10). When considering relative survival, the
relative risk ofdeath for patients aged 75 and over compared with
younger patients was 1.2 (95% CI = 0.9-1.6).
Prognosis was highly dependent on stage at diagnosis and
treatment. Inpatients aged 75 years and over, 5-yearcrude survival
rates were 37.2% aftercurative resection, 4.4% aftermedical treat-
ment, 1.7% after palliative resection and 0% after surgery without
resection (P < 0.001). Corresponding figures for relative survival
were 66.3%, 8.9%, 2.8% and 0% (P < 0.001). Five-year survival
rates and loss oflife expectancy according to stage atdiagnosis are
given in Table 3. Crude 5-year survival rates varied from 55.6%
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Figure 1 Five-year crude survival rates by three-year period and age.
--, <75 years; --, 2 75 years.
for cancers limited to the digestive tract wall to 1.6% for
metastatic cancers (P < 0.001). Corresponding relative survival
rates varied from 93.2% to 2.7% (P < 0.001). Significant differ-
ences were also observed in prognosis according to Dukes' stage
in patients who underwent curative surgery.
Crude 5-year survival rates improved over the study period in
both age groups but more noticeably after age 75 years (Figure 1).
In patients under 75, they rose from 36.0% during the 1976-78
period to 43.7% during the 1985-87 period (P> 0.10). For the
same periods, a twofold increase in survival rates was observed in
patients aged 75 years and over, from 15.1% to 29.2% (P <0.001).
This corresponded to a mean 3-year increase in survival for both
sexes combined of +4.2% (P < 0.01), more marked in women
(+6.5%, P < 0.001) than in men (+ 1.3%, P> 0.10).
Crude 5-year survival rates after curative surgery in elderly
patients showed a non-significant rise from 28.8% during the
1976-78 period to 35.6% during the 1985-87 period (P> 0.10).
No significant changes in survival rates over time were observed
for the different stage categories.
DISCUSSION
This study has demonstrated significant improvements in diag-
nostic and therapeutic approaches over the past 15 years, which
have been reflected improvements in survival data for all patients
with colon cancer, but most noticeably for the elderly. The gap that
has separated younger from elderly patients is closing. Although
there have been recent reports from hospital series to the same
effect (Bader, 1986; Kirtland and Hobler, 1986; Payne et al, 1986;
Waldron et al, 1986; Irvin, 1988; Lewis and Khoury, 1988;
Fielding et al, 1989; Ozoux et al, 1990; Arnaud et al, 1991), often
indicating more optimistic figures (Brown et al, 1988), these
reports are limited by unavoidable selection bias, especially for
elderly patients. A community-based cancer registry has the
advantage of providing a non-biased and detailed view of time
trends in the management of cancer, without the limitations due to
recruitment, which often varies with time.
The increase in the proportion ofcancers limited to the digestive
tract wall, particularly in the elderly, reflects improvements in
both diagnostic strategies and the chosen therapeutic approach.
Improvement in stage at diagnosis follows the increasing impor-
tance of colonoscopy in diagnosis. In our series, the proportion of
elderly patients with colon cancer for whom colonoscopy was
performed increased by 8.4% per year between 1976 and 1990
(unpublished data). Improvements in colonoscopic technique and
in sedation mean that this examination is now often more tolerable
for elderly patients than a double-contrast barium enema. The
improvement in diagnosis is also reflected in a higher detection
rate of malignant polyps in recent years (Pillon et al, 1991).
A concern when studying time trends in stage at diagnosis is a
possible change in staging owing to improvement in diagnostic
procedures. This usually results in an increase in the proportion of
advanced tumours: small metastases become more and more
easily detected by the systematic use of ultrasonography and
body-scan examinations. Our results demonstrate a decrease
rather than an increase in the proportion of metastatic cancers,
showing that such a bias is unlikely to have occurred to a major
extent. However, it is possible that improvements are even more
extensive than described. With regard to the classification of
operated tumours, major changes in classification are also
unlikely. A previous study in this series demonstrated that the
mean number of examined lymph nodes did not change over the
study period (Michiels et al, 1994). This stability in classification
is paralleled by the absence of variation in survival rates by stage
at diagnosis, whereas a change in classification usually results in
a 'Will Roger's effect' (Feinstein et al, 1985), i.e. an apparent
improvement in survival by stage.
Another reason for the increase in the proportion of cancers
limited to the digestive tract wall is a higher rate of surgery in
elderly patients, which is associated with a decrease in the propor-
tion of cancers of undetermined stage. It is interesting to note that
this category is very restricted in younger patients, representing
about 4% of the cases, with a very stable rate over the entire study
period. In elderly patients, such cancers represented as much as
16% of the cases at the beginning of the study, but dropped to less
than 5% at the end ofthe study, a value very close to that observed
in younger patients.
The most striking evolution in the management of elderly
patients with colon cancer lies in the rate of curative surgery,
which almost doubled over the 15-year study period, reaching
80% of all cases during the last 3-year period, 1988-90. This
proportion is similar to that observed in younger patients for the
same period. There are several reasons explaining such trends.
Improvement in anaesthetic and resuscitation techniques have
probably played a major part, but there has also been a change in
the outlook of medical and surgical practitioners in charge of
elderly patients. Our data demonstrate that age is no longer a
limiting factor in the treatment of patients with colon cancer.
More evidence for this is the major improvement in the rate of
operative mortality which, although still higher than in younger
patients, decreased steadily over the study period. This is all the
more noticeable as the proportion of patients who were offered
surgery increased. It is therefore probable that on average the
medical state of patients who undergo surgery is more severe
than it was in the past; the results might have been even better
had the study been restricted to the same type of patients at the
beginning and at the end of the study. The objectives of surgery
in elderly patients are to improve quality of life and, if possible,
survival, with a minimal risk of operative mortality, morbidity
and loss of autonomy (Bader, 1986). This has been achieved
by improvement in the perioperative management of elderly
patients, by thorough evaluation and preoperative correction of
associated medical conditions and by improvement of post-
operative resuscitation.
The decrease in post-operative mortality is one component of
the overall decrease in mortality. A similar improvement in
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survival after colorectal cancer has been demonstrated in Nordic
countries as well as in a recent US series (Boring et al, 1992). In
Finland (Jarvinen et al, 1988), increased survival was docu-
mented over the 1976-85 decade by comparison with the
previous one, together with an increase in the proportion ofearly-
stage cancers and a decrease in operative mortality. The Norway
population-based study (The'Norwegian Cancer Registry, 1980),
comparing earlier periods (1972-75 vs 1963-67) also demon-
strated a significant, but smaller, increase in overall survival in
patients over 75 years.
This study has enabled us to establish the real impact ofage on
survival from colon cancer. Age is often shown as an important
prognostic factor in models ofcrude survival. However, our data,
corrected for life expectancy, demonstrated that elderly patients
survive as well as younger patients. The overall relative risk of
death for elderly compared with younger patients was close
to one. Differences in crude survival rates according to
age can be explained by associated medical disorders, whose
frequency obviously increases age, and not by the cancer itself.
Use of models ofrelative survival in such studies (Hakulinen and
Abeywickrama, 1985), which make explicit the real impact of
age on mortality due to the disease, is of great importance in
terms ofclinical management, as misunderstandings surrounding
the impact ofage could lead to a fatalistic attitude towards elderly
patients.
Our data have also demonstrated significant differences
between elderly men and women with regard to the management
ofpatients with colon cancer. Improvements in prognostic figures
in elderly patients have mostly benefited women, who fared
worse than men at the beginning of the study period. (They had
undergone curative surgery less frequently, had been diagnosed
more often at a late stage, and had a poorer survival rate than men
in the same age group.) This gap is closing through time. The
reasons for the initial difference are not clear. Some of it may
have been due to the higher proportion of cancers of the right
colon in women than in men (Faivre et al, 1989), which tend to be
diagnosed late and to have a poor prognosis; improvements in
diagnostic techniques may have benefited these proximal
tumours.
In conclusion, our study demonstrates, with data drawn from the
whole area and not just from specialized centres, that significant
progress has been achieved in the management ofelderly patients
with colon cancer that has benefited the whole population. The
remaining differences between elderly and younger patients
suggest that there is still scope for further improvement: wide-
spread dissemination among public health advisors and clinicians
of hopeful results such as those from the present study should
further encourage good management of elderly colon cancer
patients.
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